Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

One Less Worry For Europe's Unified Patent Court After UK Ratifies Key Agreement

Executive Summary

Europe’s UPC still cannot start until and unless a legal challenge in Germany is settled in favor of the court, but the UK’s ratification this week means that discussions about the UK’s post-Brexit participation in the new systemcan now start properly.

You may also be interested in...



Long-Awaited Brexit White Paper Lays Out UK’s Plans For Medicines Regulation

The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.

Hungarian Court Decision Threatens Unified Patent Court Viability

Hungary has decided that Europe’s forthcoming Unified Patent Court Agreement is not compatible with its constitution. It will now be more important than ever to keep a close watch for possible new constitutional complaints in other countries.

Luxembourg Approves Key Unified Patent Court Instrument But Uncertainties Continue

Luxembourg will be hosting the UPC’s Court of Appeal and Registry but it is still not clear when or even whether Europe’s new common patent court will be introduced.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS122989

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel